Skip to main content
Livermore
Livermore
ZHEN

Millennium Management LLC

SEC CIK
0001273087
Latest filing
Aug 14, 2026

FATE holding history

Fate Therapeutics Inc in every 13F filed by Millennium Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overviewAll 13F holders of FATEFull Q2 2026 holdings

Shares (Q2 2026)
2,433,978
Value
$6.57M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of FATE by Millennium Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,433,978$6.57M<0.1%+2,433,978NewHolders
Q1 20260$00.0%−522,617−100.0%Sold outHolders
Q4 2025522,617$513.5K<0.1%−441,254−45.8%ReducedHolders
Q3 2025963,871$1.21M<0.1%+84,183+9.6%AddedHolders
Q2 2025879,688$985.3K<0.1%+564,811+179.4%AddedHolders
Q1 2025314,877$248.8K<0.1%−98,315−23.8%ReducedHolders
Q4 2024413,192$681.8K<0.1%+142,576+52.7%AddedHolders
Q3 2024270,616$947.2K<0.1%−176,052−39.4%ReducedHolders
Q2 2024446,668$1.47M<0.1%+446,668NewHolders
Q1 20240$00.0%−893,648−100.0%Sold outHolders
Q4 2023893,648$3.34M<0.1%−1,170,590−56.7%ReducedHolders
Q3 20232,064,238$4.38M<0.1%+1,439,177+230.2%AddedHolders
Q2 2023625,061$2.98M<0.1%−1,107,926−63.9%ReducedHolders
Q1 20231,732,987$9.88M<0.1%−1,131,489−39.5%ReducedHolders
Q4 20222,864,476$28.9M<0.1%+2,223,752+347.1%AddedHolders
Q3 2022640,724$14.4M<0.1%−89,047−12.2%ReducedHolders
Q2 2022729,771$18.1M<0.1%+419,627+135.3%AddedHolders
Q1 2022310,144$12.0M<0.1%+289,967+1,437.1%AddedHolders
Q4 202120,177$1.18M<0.1%−93,384−82.2%ReducedHolders
Q3 2021113,561$6.73M<0.1%−53,973−32.2%ReducedHolders
Q2 2021167,534$14.5M<0.1%−90,444−35.1%ReducedHolders
Q1 2021257,978$21.3M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.